Article metrics

Download PDFPDF
Abatacept is second to rituximab at risk of HBsAg reverse seroconversion in patients with rheumatic disease

 

Online download statistics by month:

Online download statistics by month: June 2021 to August 2021

AbstractFullPdf
Jun 2021584828
Jul 2021225183126
Aug 2021504344
Total333274198